Umbilical Cord Tissue

Umbilical cord tissue is a part (fragment) of the umbilical cord that is rich in mesenchymal stem cells. These stem cells have great potential in regenerative medicine, given their ability to differentiate into cartilage, muscle and nerve cells.

Umbilical cord tissue stem cell benefits:

During the transplantation procedure, cord blood mesenchymal stem cells do not possess the risk of rejection and, if necessary, they can be used by any family member with a 100% compatibility rate

Simultaneous use of umbilical cord blood and tissue leads to better treatment results that, in turn, provide more treatment options and improve the therapeutic potential

Umbilical Cord Tissue Stem Cells Recently, scientists discovered that umbilical cord - the link that connects the foetus to the placenta and protects blood vessels from compression - is a rich source of mesenchymal stem cells. The umbilical cord tissue contains a gel-like substance, called Wharton's Jelly, which is found around the umbilical cord arteries and the umbilical cord vein. This mucous connective tissue contains mesenchymal stem cells, which are far more superior than other mesenchymal cells that are extracted from other sources.

Mesenchymal cells have a wide range of biological characteristics: these cells decrease inflammation, stimulate blood vessel growth, improve other cell survival rate and they can differentiate into a variety of other cell types. Mesenchymal stem cells can migrate into the damaged and inflamed tissue sites to take part in organ and tissue regeneration.

Mesenchymal stem cells, which have been isolated from the umbilical cord, have several characteristics:

These are very active "new" stem cells, which can be effectively used in regenerative therapy.

Welcome to iVF Riga Stem Cell Center. This site uses cookies to improve user experience and optimize its performance. Continuing to use this website means you agree to use cookies on Vivacell website. Read moreThe withdrawal of consent does not affect the processing of data carried out at the time when the Сlient's consent was in force.